Sulfasalazine for juvenile rheumatoid arthritis
Content provided by Healthwise
Examples
| Brand Name | Generic Name |
| Azulfidine | sulfasalazine |
Sulfasalazine is a combination of salicylic acid (the active ingredient in aspirin) and an antibiotic, sulfapyridine.
How It Works
Sulfasalazine may reduce joint inflammation caused by juvenile rheumatoid arthritis (JRA).
Why It Is Used
Sulfasalazine is considered a second-line treatment for JRA. Its use is reserved for children with JRA who do not respond to nonsteroidal anti-inflammatory drugs (NSAIDs) or methotrexate. Children who are allergic to sulfa medicines or salicylates cannot use this medicine.
How Well It Works
Some data indicate that the use of sulfasalazine is effective in the treatment of JRA, particularly children with polyarticular JRA (polyarthritis) and pauciarticular JRA (oligoarthritis).1
Side Effects
Children with systemic JRA are most likely to experience severe side effects and therefore are not treated with sulfasalazine.2
Common but not serious side effects may include:
- Nausea, gas, diarrhea or loose stools, stomachache.
- Headache.
Uncommon side effects include:
- Severe allergic reactions, rashes.
- Lowered blood counts.
- Liver inflammation.
- Severe mouth sores and blisters.
It is common practice to do a complete blood count (CBC) every 6 to 12 months when using sulfasalazine.
See Drug Reference for a full list of side effects. (Drug Reference is not available in all systems.)
What To Think About
Positive effects from sulfasalazine treatment can take 1 to 3 months to become apparent, which is faster than some other second-line medicines.2
Sulfasalazine is considered safer, but is generally less effective, than methotrexate. A child who cannot take or hasn't responded to first-line NSAID treatment or to methotrexate may be given sulfasalazine.
Sulfasalazine can cause severe side effects in children with systemic JRA.
Complete the new medication information form (PDF) (What is a PDF document?) to help you understand this medication.
References
Citations
Brooks CD (2001). Sulfasalazine for the management of juvenile rheumatoid arthritis. Journal of Rheumatology, 28(4): 845–853.
Giannini EH, Brunner HI (2005). Treatment of juvenile rheumatoid arthritis. In WJ Koopman, LW Moreland, eds., Arthritis and Allied Conditions, 15th ed., vol. 1, pp. 1301–1318. Philadelphia: Lippincott Williams and Wilkins.
Credits
| Author | Shannon Erstad, MBA/MPH |
| Editor | Kathleen M. Ariss, MS |
| Associate Editor | Pat Truman, MATC |
| Primary Medical Reviewer | Michael J. Sexton, MD - Pediatrics |
| Specialist Medical Reviewer | Stanford M. Shoor, MD - Rheumatology |
| Last Updated | June 25, 2008 |
| Last updated: | June 25, 2008 |
|---|---|
| Author: | Shannon Erstad, MBA/MPH |
| Reviewed By: | Michael J. Sexton, MD - Pediatrics, Stanford M. Shoor, MD - Rheumatology |
| Editors: | Kathleen M. Ariss, MS, Pat Truman, MATC |
© 1995-2007, Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
This information is not intended to replace the advice of a doctor. By using AOL Body, you indicate that you have read, understood, and agreed to our Terms of Service, and AOL Body Advertising Policy. Read more about our content partners.
Search
Related Articles
Where Does it Hurt?
If you're experiencing aches and pains we can help you find answers. Find out what your symptoms mean for your health.
